Oliver J. Spandow insider trades
Open-market stock purchases and sales by Oliver J. Spandow, Director at Nephros Inc, from SEC Form 4 filings since Aug 10, 2018.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -48%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Nov 10, 2025 | NEPH Nephros Inc | Bought (not open market) | — |
Companies traded
- NEPH Nephros Inc: 2 buys, last Nov 10, 2025